Suspension of trading
Oncternal Therapeutics, Inc. Share Price
Stocks
ONCT
US68236P2065
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5266 USD | -24.11% |
|
-.--% | - |
| 01/07/25 | Oncternal Therapeutics, Inc. Appoints Craig R. Jalbert as CEO | CI |
| 01/07/25 | Oncternal Therapeutics, Inc. Announces Management Changes | CI |
| Market Cap | 1.56M 1.36M 1.26M 1.16M 2.18M 150M 2.23M 15.02M 5.91M 73.51M 5.85M 5.72M 253M | P/E 2022 |
-1.19x | P/E 2023 | -0.8x |
|---|---|---|---|---|---|
| Enterprise Value | -32.38M -28.3M -26.11M -24.07M -45.36M -3.12B -46.37M -312M -123M -1.53B -122M -119M -5.26B | EV / Sales 2022 |
-4.9x | EV / Sales 2023 | -2.95x |
| Free-Float |
90.77% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | -24.11% |
| 3 years | 0.53 |  | 13.14 |
| 5 years | 0.53 | | 92.6 |
| 10 years | 0.53 | | 211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Vincent
DFI | Director of Finance/CFO | 63 | 31/03/2017 |
Yisrael Katz
CTO | Chief Tech/Sci/R&D Officer | - | 30/06/2023 |
Rajesh Krishnan
CTO | Chief Tech/Sci/R&D Officer | 53 | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Hale
CHM | Chairman | 77 | 30/11/2018 |
Dan Kisner
BRD | Director/Board Member | 79 | 06/06/2019 |
William LaRue
BRD | Director/Board Member | 75 | 30/11/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20/06/24 | Free | Director | 2,200 | 0.0743% | ||
| 20/06/24 | Free | Director | 2,200 | 0.0743% | ||
| 20/06/24 | Free | Founder | 3,300 | 0.1115% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -24.11% | -.--% | -.--% | -94.16% | 1.56M | |
| -1.29% | -3.11% | -0.35% | +3.09% | 49.18B | |
| +3.90% | -0.39% | +386.06% | +593.85% | 39.58B | |
| -1.70% | +4.46% | +5.93% | +60.25% | 34.69B | |
| -2.01% | -0.76% | +28.41% | -8.01% | 34.42B | |
| +0.06% | +0.34% | +2.38% | +34.38% | 27.11B | |
| +0.46% | -3.49% | - | - | 16.21B | |
| -0.04% | -0.09% | +72.42% | +115.55% | 15.36B | |
| +1.12% | +1.91% | +14.54% | +19.16% | 14.05B | |
| 0.00% | +1.36% | +18.43% | -30.79% | 13.02B | |
| Average | -2.36% | -2.56% | +58.65% | +77.03% | 24.36B | |
| Weighted average by Cap. | -0.05% | -0.18% | +79.44% | +123.31% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.49M 1.3M 1.2M 1.11M 2.09M 143M 2.13M 14.36M 5.65M 70.28M 5.6M 5.47M 242M | 785K 686K 633K 583K 1.1M 75.6M 1.12M 7.57M 2.98M 37.02M 2.95M 2.88M 127M |
| Net income | -44.17M -38.6M -35.62M -32.83M -61.88M -4.25B -63.26M -426M -167M -2.08B -166M -162M -7.17B | -39.48M -34.5M -31.84M -29.35M -55.31M -3.8B -56.54M -381M -150M -1.86B -148M -145M -6.41B |
| Net Debt | -63.64M -55.61M -51.32M -47.3M -89.16M -6.13B -91.13M -613M -241M -3B -239M -234M -10.33B | -33.94M -29.66M -27.37M -25.23M -47.55M -3.27B -48.6M -327M -129M -1.6B -127M -125M -5.51B |
Employees
29
- Stock Market
- Stocks
- ONCT Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
